AP-1 and vitamin D receptor (VDR) signaling pathways converge at the rat osteocalcin VDR element: Requirement for the internal activating protein-1 site for vitamin D-mediated trans-activation

Endocrinology

Volumn 140, Issue 1, 1999, Pages 63-70

  Aslam, Fauzia ^a   McCabe, Laura ^a,b   Frenkel, Baruch ^a   Van Wijnen, André J ^a   Stein, Gary S ^a   Lian, Jane B ^a   Stein, Janet L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; OSTEOCALCIN; RETINOID; STEROID HORMONE; SYNAPSIN I; TRANSCRIPTION FACTOR; VITAMIN D RECEPTOR;

ARTICLE; BINDING SITE; CELL CULTURE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; RAT; RECEPTOR BINDING; SEQUENCE ANALYSIS; TISSUE SPECIFICITY; TRANSACTIVATION;

EID: 0032893076     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.1.6429     Document Type: Article

References (56)

1. 1. Tzukerman M, Zhang XK, Pfahl M 1991 Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate: a molecular analysis. Mol Endocrinol 5:1983-1992
2. 2. Salbert G, Fanjul A, Piedrafita FJ, Lu XP, Kim SJ, Tran P, Pfahl M 1993 Retinoic acid receptors and retinoid X receptor-α down-regulate the transforming growth factor-β1 promoter by antagonizing AP-1 activity. Mol Endocrinol 7:1347-1356
3. 3. Desbois C, Aubert D, Legrand C, Pain B, Samarut J 1991 A novel mechanism of action for v-ErbA: abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors. Cell 67:731-740
4. 4. Jonat C, Rahmsdorf HJ, Park K-K, Cato ACB, Gebel S, Ponta H, Herrlich P 1990 Antitumor promotion and anti-inflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189-1204
5. 5. Lucibello FC, Slater EP, Jooss KU, Beato M, Muller R 1990 Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB. EMBO J 9:2827-2834
6. 6. Schule R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM 1990 Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217-1226
7. 7. Yang-Yen HF, Chambard J-C, Sun Y-L, Smeal T, Schmidt TJ, Drouin J, Karin M 1990 Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DKA binding due to direct protein-protein interaction. Cell 62:1205-1215
8. 8. Gaub MP, Bellard M, Scheuer I, Chambon P, Sassone-Corsi P1990 Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex. Cell 63:1267-1276
9. 9. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR 1990 Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249:1266-1272
10. 10. Harrison RJ, McNeil GP, Dobner PR 1995 Synergistic activation of neurotensin/neuromedin N gene expression by c-Jun and glucocorticoids: novel effects of Fos family proteins. Mol Endocrinol 9:981-993
11. 11. Lian JB, Stein GS, Stein JL, van Wijnen AJ, McCabe L, Banerjee C, Hoffmann H 1996 The osteocalcin gene promoter provides a molecular blueprint for regulatory mechanisms controlling bone tissue formation: role of transcription factors involved in development. Conn Tissue Res 35:15-21
12. 12. Owen TA, Bortell R, Yocum SA, Smock SL, Zhang M, Abate C, Shalhoub V, Aronin N, Wright KL, van Wijnen AJ, Stein JL, Curran T, Lian JB, Stein GS 1990 Coordinate occupancy of AP-1 sites in the vitamin D responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription. Proc Natl Acad Sci USA 87:9990-9994
13. 13. Banerjee C, Stein JL, van Wijnen AJ, Frenkel B, Lian JB, Stein GS 1996 Transforming growth factor-β1 responsiveness of the rat osteocalcin gene is mediated by an activator protein-1 binding site. Endocrinology 137:1991-2000
14. 14. Aslam F, Shalhoub V, van Wijnen AJ, Banerjee C, Bortell R, Shakoori AR, Litwack G, Stein JL, Stein GS, Lian JB 1995 Contributions of distal and proximal promoter elements to glucocorticoid regulation of osteocalcin gene transcription. Mol Endocrinol 9:679-690
15. 15. McCabe LR, Banerjee C, Kundu R, Harrison RJ, Dobner PR, Stein JL, Lian JB, Stein GS 1996 Developmental expression and activities of specific fos and jun proteins are funtionally related to osteoblast maturation: role of fra-2 and jun D during differentiation. Endocrinology 137:4398-4408
16. 16. Hadman M, Loo M, Bos TJ 1993 In vivo viral and cellular Jun complexes exhibit differential interactions with a number of in vitro generated "AP-1 and CREB-like" target sequences. Oncogene 8:1895-1903
17. 17. Ryseck RP, Bravo R 1991 c-JUN, JUN B and JUN D differ in their binding affinities to AP-1 and CRE consensus sequence: effect of FOS proteins. Oncogene 6:533-542
18. 18. Markose ER, Stein JL, Stein GS, Lian JB 1990 Vitamin D-mediated modifications in protein-DNA interactions at two promoter elements of the osteocalcin gene. Proc Natl Acad Sci USA 87:1701-1705
19. 3. Proc Natl Acad Sci USA 87:369-373
20. 3-mediated transcriptional activation. Mol Endocrinol 5:373-385
21. 21 . Morrison NA, Shine J, Fragonas JC, Verkest V, McMenemy L, Eisman JA 1989 1,25-Dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 246:1158-1161
22. 22. Kerner SA, Scott RA, Pike JW 1989 Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. Proc Natl Acad Sci USA 86:4455-4459
23. 23. Guo B, Aslam F, van Wijnen AJ, Roberts SGE, Frenkel B, Green M, DeLuca H, Lian JB, Stein GS, Stein JL 1997 YY1 regulates VDR/RXR mediated transactivation of the vitamin D responsive osteocalcin gene. Proc Natl Acad Sci USA 94:121-126
24. 24. Merriman HL, van Wijnen AJ, Hiebert S, Bidwell JP, Fey E, Lian J, Stein J, Stein GS 1995 The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter. Biochemistry 34:13125-13132
25. 25. Ozono K, Liao J, Kerner SA, Scott RA, Pike JW 1990 The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer. J Biol Chem 265:21881-21888
26. 26. Schüle R, Umesono K, Mangelsdorf DJ, Bolado J, Pike JW, Evans RM 1990 Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 61:497-504
27. 27. Owen TA, Bortell R, Shalhoub V, Heinrichs A, Stein JL, Stein GS, Lian JB 1993 Postproliferative transcription of the rat osteocalcin gene is reflected by-vitamin D-responsive developmental modifications in protein-DNA interactions at basal and enhancer promoter elements. Proc Natl Acad Sci USA 90:1503-1507
28. 28. Demay MB, Kiernan MS, DeLuca HF, Kronenberg HM 1992 Characterization of 1,25-dihydroxyvitamin D3 receptor interactions with target sequences in the rat osteocalcin gene. Mol Endocrinol 6:557-562
29. 29. Schepmoes G, Breen E, Owen TA, Aronow MA, Stein GS, Lian JB 1991 Influence of dexamethasone on the vitamin D-mediated regulation of osteocalcin gene expression. J Cell Biochem 47:184-196
30. 30. Sambrook J, Fritsch EF, Maniatis T 1988 Molecular Cloning: A Laboratory Manual, ed 2 Cold Spring Harbor Laboratory, Cold Spring Harbor
31. 31 . Staal A, van Wijnen AJ, Birkenhäger JC, Pols HAP, Prahl J, DeLuca H, Gaub M-P, Lian JB, Stein GS, van Leeuwen JPTM, Stein JL 1996 Distinct conformations of VDR/RXRα heterodimers are specified by dinucleotide differences in the vitamin D responsive elements of the osteocalcin and osteopontin genes. Mol Endocrinol 10:1444-1456
32. 32. Bortell R, Owen TA, Bidwell JP, Gavazzo P, Breen E, van Wijnen AJ, DeLuca HF, Stein JL, Lian JB, Stein GS 1992 Vitamin D-responsive protein-DNA interactions at multiple promoter regulatory elements that contribute to the level of rat osteocalcin gene expression. Proc Natl Acad Sci USA 89:6119-6123
33. 3-activated expression of the rat osteocalcin gene. Mol Cell Biol 13:5907-5917
34. 3 on gene transcription. J Biol Chem 264:2279-2282
35. 3 receptor-mediated enhancement of osteocalcin gene transcription: effects of perturbing phosphorylation pathways by okadaic acid and staurosporine. Endocrinology 136:5685-5693
36. 36. Logan SK, Garabedian MJ, Campbell CE, Werb Z 1996 Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J Biol Chem 271:774-782
37. 37. Candeliere GA, Prud'homme J, St-Arnaud R 1991 Differential stimulation of Fos and Jun family members by calcitrol in osteoblastic cells. Mol Endocrinol 5:1780-1788
38. 38 Lasky SR, Iwata K, Rosmarin AG, Caprio DG, Maizel AL 1995 Differential regulation of JunD by dihydroxycholecalciferol in human chronic myelogenous leukemia cells. J Biol Chem 270:19676-19679
39. 39. Bubulya A, Wise SC, Shen X-Q, Burmeister LA, Shemshedini L 1996 c-Jun can mediate androgen receptor-induced transactivation. J Biol Chem 271:24583-24589
40. 3 receptor and other nonreceptor transcription factors. Mol Endocrinol 8:1593-1604
41. 41. Toohey MG, Lee JW, Huang M, Peterson DO 1990 Functional elements of the steroid hormone-responsive promoter of mouse mammary tumor virus. J Virol 64:4477-4488
42. 42 Jacq X, Brou C, Lutz Y, Davidson I, Chambon P, Tora L 1994 Human TAFI130 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79:107-117
43. 43. Baniahmad C, Nawaz Z, Baniahmad A, Gleeson MA, Tsai MJ, O'Malley BW 1995 Enhancement of human estrogen receptor activity by SPT6: a potential coactivator. Mol Endocrinol 9:34-44
44. 44. Onate SA, Tsai SY, Tsai MJ, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
45. 45. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG 1995 Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 14:3741-3751
46. 46. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG 1996 A CBP integrator complex mediates transcriptional activation and AP-1 inhibition bv nuclear receptors. Cell 85:403-414
47. 47. Baudino TA, Kraichely DM, Jefcoat SCJ, MacDonald PN 1997 Isolation and characterization of NCoA-62, a novel coactivator protein involved in vitamin D-mediated transcription. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone. University of California, Riverside, pp 320-321
48. 48. Hoffmann HM, Catron KM, van Wijnen AJ, McCabe LR, Lian JB, Stein GS, Stein JL 1994 Transcriptional control of the tissue-specific, developmentally regulated osteocalcin gene requires a binding motif for the Msx family of homeodomain proteins. Proc Natl Acad Sci USA 91:12887-12891
49. 49 Ryoo H-M, Hoffmann HM, Beumer TL, Frenkel B, Towler DA, Stein GS, Stein JL, van Wijnen AJ, Lian JB 1997 Stage-specific expression of DIx-5 during osteoblast differentiation: involvement in regulation of osteocalcin gene expression. Mol Endocrinol 11:1681-1694
50. 3 inhibits osteocalcin expression in mouse though an indirect mechanism. J Biol Chem 272:110-116
51. 51. Banerjee C, Hiebert SW, Stein JL, Lian JB, Stein GS 1996 An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc Natl Acad Sci USA 93:4968-4973
52. 52. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G 1997 Osf2/Cbfal: a transcriptional activator of osteoblast differentiation. Cell 89:747-754
53. 53. Banerjee C, McCabe LR, Choi J-Y, Hiebert SW, Stein JL, Stein GS, Lian JB 1997 Runt homology domain proteins in osteoblast differentiation: AML-3/CBFA1 is a major component of a bone specific complex. J Cell Biochem 66:1-8
54. 54 Lindenmuth DM, van Wijnen AJ, Hiebert S, Stein JL, Lian JB, Stein GS 1997 Subcellular partitioning of transcription factors during osteoblast differentiation: developmental association of the AML/CBFα/PEBP2α-related transcription factor-NMP-2 with the nuclear matrix. J Cell Biochem 66:123-132
55. 55. Lian JB, Shalhoub V, Aslam F, Frenkel B, Green J, Hamrah M, Stein GS, Stein JL 1997 Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D downregulates osteocalcin gene expression. Endocrinology 138:2117-2127
56. 56. Clemens TL, Tang H, Maeda S, Kesterson RA, DeMayo F, Pike JW, Gundberg CM 1997 Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes. J Bone Miner Res 12:1570-1576